Clinical Trials · NCT07200622
Oral Semaglutide in Patients With Alzheimer's Disease
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Imperial College London
- Enrollment
- 60
- Start date
- Sep 2025
- Locations
- See registry
- Primary endpoint
- To evaluate the safety and tolerability of oral semaglutide in an AD population.